MomentumLab combines institutional-grade momentum research with a clear monthly model, so you can allocate with conviction instead of reacting to noise.
Simulated results use current index constituents. Survivorship bias applies. Costs excluded. Past performance ≠ future results.
Not forever. Not every one. But on average and over multi-month horizons, past winners outperform past losers. This effect is robust across countries, decades, asset classes, and sectors and it persists for reasons that are deeply human.
Returns over the past six months significantly predict returns over the following six months. A strategy that buys past winners and sells past losers generates significant abnormal returns over the 1965 to 1989 period.
Every view below is live in the product. Move from raw rankings to market context, then to clear monthly decisions.
Find the strongest names fast. Filter the noise, compare leaders, and focus on what matters.
| # | Ticker | Sector | 1M | Score |
|---|---|---|---|---|
| 1 | SNDK🔥 | Info Tech | +45.0% | +427.9% |
| 2 | LITE🔥 | Info Tech | +27.2% | +307.8% |
| 3 | WDC🔥 | Info Tech | +37.8% | +181.6% |
| 4 | CIEN🔥 | Info Tech | +30.7% | +172.6% |
| 5 | COHR🔥 | Info Tech | +44.8% | +141.8% |
| 6 | STX🔥 | Info Tech | +40.1% | +139.0% |
Every tool is built to answer one question: which stocks are leading right now, and is this a safe environment to hold them?
Spot the strongest stocks in seconds, compare leaders side by side, and focus your attention where momentum is actually building.
See at a glance whether market conditions support taking risk, so you can stay patient in weak phases and lean in when strength returns.
Follow a clear monthly model with fixed rules, built to ride strength when trends are healthy and step back when they are not.
Get clean market context that shows if momentum is broad or narrow, so your decisions are based on structure instead of headlines.
Review how the approach behaves across multiple cycles, drawdowns, and recoveries to build conviction before you commit capital.
Map realistic long-term outcomes for your portfolio and turn your investing plan into a concrete path you can stick to.
Track momentum shifts between monthly rebalances and see changing leadership early, without needing to monitor markets all day.
Keep your best ideas organized in one place and quickly see which names are strengthening, stalling, or quietly breaking out.
Receive one clear monthly brief with the key updates that matter, so you can act fast without getting lost in noise.
Built forLong-term, rules-based investors who want a structured monthly process and clear market context.
Not forDay trading or discretionary prediction-based timing.
A long-term view of model behavior across uptrends, drawdowns, and recoveries.
Everything you need to explore momentum and understand the platform.
Create free accountEverything. No limits. Full screener, all positions, daily monitor, insights, and more.
Start 7-day free trialPro trial requires a payment method. Cancel before day 7 to stay on Free. No commitment.
MomentumLab is a momentum research platform. It helps you rank stocks, read market health, and follow a clear monthly framework inside one workspace. You get data, context, and structured outputs; you decide how to act.
Momentum is the empirical tendency for relative winners to keep outperforming over the following months. Since the classic work of Jegadeesh & Titman (1993), the effect has been widely studied across markets. MomentumLab measures this across 1M, 3M, 6M, and 9M horizons to support disciplined research.
No. MomentumLab is an information and research service. The platform provides the output of quantitative momentum models for informational purposes only. No recommendation to buy, sell, or hold any security is made or implied. All investment decisions are your own responsibility.
When you start Pro, you add a payment method and get full Pro access right away for seven days. Cancel before the trial ends and you will not be charged, and your account goes back to the Free plan. If you keep Pro, billing starts when the trial ends at the price you chose (monthly or yearly).
Yes. Any investment can result in partial or total loss of capital. Historical simulations show how the framework behaved in prior drawdowns, but future outcomes can differ materially. Backtests are subject to survivorship bias and exclude transaction costs and taxes.
Plans are billed monthly or yearly (yearly saves about 17%). You can switch or cancel from your account settings; access continues until the end of the paid period.
Yes. No lock-in. Cancel from your account settings. Your access continues until the end of the billing period, then you move to the free plan.
Stay aligned with market leadership, understand regime changes, and decide with a consistent monthly rhythm.
Free forever. Pro has a 7-day trial.